# ACT-DE for Diabetes Distress and HbA1c in Adults With Type 2 Diabetes

> **NCT05584085** · NA · UNKNOWN · sponsor: **Chinese University of Hong Kong** · enrollment: 176 (estimated)

## Conditions studied

- Acceptance and Commitment Therapy
- Diabetes Education
- Diabetes Distress
- HbA1c
- Psychological Flexibility
- Diabetes Self-management
- Diabetes Management Self-efficacy

## Interventions

- **BEHAVIORAL:** ACT-DE

## Key facts

- **NCT ID:** NCT05584085
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-10-15
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-11-30
- **Target enrollment:** 176 (ESTIMATED)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05584085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05584085, "ACT-DE for Diabetes Distress and HbA1c in Adults With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05584085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
